Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Cynapsus Therapeutics Inc (NASDAQOTCBB:CYNA)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQOTCBB:CYNA will perform against the market?

Add Stock to CAPS Watchlist

All Players

2 Outperform
1 Underperform
 

All-Star Players

0 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:CYNA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMusta (30.66)
Submitted March 20, 2015

Cynapsus is starting phase 3 trial for it's candidate drug for OFF episodes associated with Parkinson's disease. The NDA should get filed in 2016. If succesful, there's huge upside and a great chance that the company gets acquired.

SmartAce (99.98)
Submitted December 30, 2014

In the land of the skunks he who has half a nose is king.Farley

NASDAQOTCBB:CYNA Summary

Fools bullish on NASDAQOTCBB:CYNA are also bullish on:

Fools bearish on NASDAQOTCBB:CYNA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CYNA.

Recs

1
Member Avatar TMusta (30.66) Submitted: 3/20/2015 6:59:33 AM : Outperform Start Price: $16.32 NASDAQ OTC:CYNA Score: -103.59

Cynapsus is starting phase 3 trial for it's candidate drug for OFF episodes associated with Parkinson's disease. The NDA should get filed in 2016. If succesful, there's huge upside and a great chance that the company gets acquired.

Leaderboard

Find the members with the highest scoring picks in CYNA.

Score Leader

redfox18

redfox18 (99.89) Score: +65.90

The Score Leader is the player with the highest score across all their picks in CYNA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
JoeySolitro1 99.99 8/22/2014 Underperform 5Y $8.87 +66.88% +104.09% +37.21 0 Comment
TMusta 30.66 3/20/2015 Outperform 3Y $16.32 -9.31% +94.28% -103.59 1 Comment
33fool < 20 2/18/2015 Outperform 5Y $18.56 -20.26% +94.32% -114.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CYNA.